Elegantly Delivering High Purity Biologics
Contact

Technology

Our Mission

Enquyst Technologies is driven by a diverse team of experienced scientists and engineers who strive to ensure that patients across the globe have access to biological therapies.

GENE THERAPY

Enquyst Technologies is applying its patented IPP technology to solve large unmet needs in the downstream purification of AAV and lentiviral vectorbased gene therapies to enable more of these types of therapies to have a viable chance at clinical translation.

  • Unprecedented high purity separation of empty vs. full capsids.
  • Scalable purification that eliminates the reliance on ion exchange chromatography.
  • Simple and Straightforward Process Development.

MONOCLONAL ANTIBODIES

Enquyst Technologies is developing novel equipment modules to deliver an end-to-end continuous process for the production of monoclonal antibodies (mAbs). The process technology is designed to:

  • Eliminate the reliance on chromatography.
  • Enable a true paradigm shift in the process development.
  • Significantly reduce manufacturing costs (CapEx and OpEx) by >80%,

Our Differentiator: IPP Technology

Enquyst Technologies has engineered its patented IPP technology to deliver:

  • Unprecedented high purity separations to abrogate immunogenicity
  • Faster and more straightforward process development
  • No yield loss
  • Continuous, chromatography-free processing in a small footprint
  • Flexibility to purify multiple classes of biologics
  • Ease of scalability
  • Low CapEx and OpEx
Elegantly Delivering High Purity Biologics

COPYRIGHT © 2023 ENQUYST TECHNOLOGIES INC – ALL RIGHTS RESERVED

Atana

Dr. Sengupta

Dr. Sengupta was one of the first scientists to demonstrate rich structural fingerprints of bioaerosols using Surface-Enhanced Raman Spectroscopy (SERS). After his PhD he joined Real-Time Analyzers, USA and where he led and participated in several small business innovation research programs in collaboration with several government agencies (NSF, NIH, DARPA, DOD, NASA, UK Home Office, etc.) He joined Dr. Reddy’s Laboratories Limited in 2013 where he was instrumental in setting up and leading a state-of-the-art GMP certified advanced analytical facility servicing more than 300 products annually. He is very experienced in regulatory and quality landscape for pharmaceuticals, product, process, and analytical development and validations, and has successfully cleared several FDA. He also championed the implementation of advanced Process Analytical Technologies (PAT) from proof-of-concept R&D to full-scale Manufacturing.  Dr. Sengupta received his dual degree in PhD (Chemistry and Nanotechnology) from the University of Washington, Seattle.

Brock Jacobites

Brock Jacobites

Brock is a highly accomplished Senior Engineer with over 15 years of experience in product development, technology development, and high-volume manufacturing. Most recently, he has developed automation equipment and mechanical solutions for solar wafer development as an Engineering Fellow. Prior to this, he was a Product Engineer in sustainable building technologies and a Lead Engineer in acoustic transducer development, where he invented industry-specific product technology, managed direct reports, and mentored junior engineers. Brock holds both a B.S. in Mechanical Engineering and an MBA from the University of Massachusetts – Amherst. He is highly skilled in open ended problem solving, mechanical design, and a broad spectrum of manufacturing processes.